Literature DB >> 14625280

cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.

Kerri M Zawadzki1, Susan S Taylor.   

Abstract

cAMP-dependent protein kinase (cAPK) contains a regulatory (R) subunit dimer bound to two catalytic (C) subunits. Each R monomer contains two cAMP-binding domains, designated A and B. The sequential binding of two cAMPs releases active C. We describe here the properties of RIIbeta and two mutant RIIbeta subunits, engineered by converting a conserved Arg to Lys in each cAMP-binding domain thereby yielding a protein that contains one intact, high affinity cAMP-binding site and one defective site. Structure and function were characterized by circular dichroism, steady-state fluorescence, surface plasmon resonance and holoenzyme activation assays. The Ka for RIIbeta is 610 nM, which is 10-fold greater than its Kd(cAMP) and significantly higher than for RIalpha and RIIalpha. The Arg mutant proteins demonstrate that the conserved Arg is important for both cAMP binding and organization of each domain and that binding to domain A is required for activation. The Ka of the A domain mutant protein is 21-fold greater than that of wild-type and the Kd(cAMP) is increased 7-fold, confirming that cAMP must bind to the mutated site to initiate activation. The domain B mutant Ka is 2-fold less than its Kd(cAMP), demonstrating that, unlike RIalpha, cAMP can access the A site even when the B site is empty. Removal of the B domain yields a Ka identical to the Kd(cAMP) of full-length RIIbeta, indicating that the B domain inhibits holoenzyme activation for RIIbeta. In RIalpha, removal of the B domain generates a protein that is more difficult to activate than the wild-type protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625280     DOI: 10.1074/jbc.M310804200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

2.  Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.

Authors:  Tsan-Wen Lu; Jian Wu; Phillip C Aoto; Jui-Hung Weng; Lalima G Ahuja; Nicholas Sun; Cecilia Y Cheng; Ping Zhang; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-30       Impact factor: 11.205

3.  Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.

Authors:  Anélia Horvath; Jérôme Bertherat; Lionel Groussin; Marine Guillaud-Bataille; Kitman Tsang; Laure Cazabat; Rosella Libé; Elaine Remmers; Fernande René-Corail; Fabio Rueda Faucz; Eric Clauser; Alain Calender; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

Review 4.  Carney complex: an update.

Authors:  Ricardo Correa; Paraskevi Salpea; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-06-30       Impact factor: 6.664

5.  Localization and quaternary structure of the PKA RIβ holoenzyme.

Authors:  Ronit Ilouz; José Bubis; Jian Wu; Yun Young Yim; Michael S Deal; Alexandr P Kornev; Yuliang Ma; Donald K Blumenthal; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-13       Impact factor: 11.205

6.  The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.

Authors:  Donald K Blumenthal; Jeffrey Copps; Eric V Smith-Nguyen; Ping Zhang; William T Heller; Susan S Taylor
Journal:  J Biol Chem       Date:  2014-08-11       Impact factor: 5.157

7.  RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR.

Authors:  Agata M Trzcińska-Daneluti; Anthony Chen; Leo Nguyen; Ryan Murchie; Chong Jiang; Jason Moffat; Lawrence Pelletier; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2015-03-29       Impact factor: 5.911

8.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

9.  Temporal sensitivity of protein kinase a activation in late-phase long term potentiation.

Authors:  MyungSook Kim; Ted Huang; Ted Abel; Kim T Blackwell
Journal:  PLoS Comput Biol       Date:  2010-02-26       Impact factor: 4.475

10.  Sensing domain dynamics in protein kinase A-I{alpha} complexes by solution X-ray scattering.

Authors:  Cecilia Y Cheng; Jie Yang; Susan S Taylor; Donald K Blumenthal
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.